|

CID-078 Monotherapy Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Circle Pharma1

Indications

  • RB1 Gene Mutation1
  • Neuroendocrine Carcinoma1
  • Refractory Solid Tumor1
  • Metastatic Solid Tumor1
  • Triple Negative Breast Cancer1

Sarasota, Florida1 trial

Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies

Florida Cancer Specialists

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.